Last reviewed · How we verify
The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet for the Treatment of Bacterial Vaginosis
Randomized, double blind, positive drug parallel comparison, multi-centre clinical trial to assess the Efficacy and Safety of Clindamycin palmitate hydrochloride dispersible tablet for the treatment of bacterial vaginosis
Details
| Lead sponsor | Guangzhou Yipinhong Pharmaceutical CO.,LTD |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 300 |
| Start date | 2016-07 |
| Completion | 2017-12 |
Conditions
- Bacterial Vaginosis
Interventions
- Clindamycin palmitate hydrochloride dispersible tablet
- Metronidazole Tablet
Primary outcomes
- Nugent score — From the first day of randomization to 4-10 and 23-33 days after the end,expected to be up to 33 days.Evaluate changes from baseline to the end of the study.
score of Vaginal secretions for Gram stain
Countries
China